OnKure Therapeutics, Inc. (OKUR)
3.57
+0.01
(+0.28%)
USD |
NASDAQ |
Sep 04, 16:00
3.40
-0.17
(-4.76%)
After-Hours: 16:32
OnKure Therapeutics Cash from Investing (Quarterly) : -9.87M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.87M |
| March 31, 2026 | -0.005M |
| December 31, 2025 | -0.009M |
| September 30, 2025 | -0.006M |
| June 30, 2025 | -0.013M |
| March 31, 2025 | -0.018M |
| December 31, 2024 | -45.38M |
| September 30, 2024 | -0.018M |
| June 30, 2024 | -0.01M |
| March 31, 2024 | -0.009M |
| December 31, 2023 | 29.01M |
| September 30, 2023 | 21.25M |
| June 30, 2023 | -69.01M |
| Date | Value |
|---|---|
| March 31, 2023 | 18.51M |
| December 31, 2022 | -26.92M |
| September 30, 2022 | -45.44M |
| June 30, 2022 | 9.083M |
| March 31, 2022 | 5.427M |
| December 31, 2021 | 8.153M |
| September 30, 2021 | -4.509M |
| June 30, 2021 | -27.00M |
| March 31, 2021 | -0.025M |
| December 31, 2020 | -0.016M |
| September 30, 2020 | 1.193M |
| June 30, 2020 | 1.00M |
| March 31, 2020 | 5.199M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| Theriva Biologics, Inc. | -0.003M |
| Nkarta, Inc. | 21.15M |
| Unicycive Therapeutics, Inc. | -0.023M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.35M |
| Cash from Financing (Quarterly) | -5.38M |
| Free Cash Flow | -47.86M |
| Free Cash Flow Per Share (Quarterly) | -0.2077 |
| Free Cash Flow to Equity (Quarterly) | -10.87M |
| Free Cash Flow to Firm (Quarterly) | -10.36M |
| Free Cash Flow Yield | -59.15% |